Skip to main content
Everything PR News
Corporate Communications

How Cannabis Rebuilt Its Reputation: 12 Years From Demonization to Normalization

EPR Editorial Team11 min read
Share
How Cannabis Rebuilt Its Reputation: 12 Years From Demonization to Normalization

Originally published December 2014. Updated October 22, 2026.

Satellite of the EPR Cannabis hub · Cannabis Rebrand-from-Demonization Anchor · Sister satellites: The Cannabis Index · Cannabis Branding for the Normalization Era · Cannabis PR: How Curaleaf, Trulieve, Cresco, Verano and Green Thumb Built Credibility

How Cannabis Rebuilt Its Reputation: 12 Years of PR Discipline From Demonization to Normalization

Cannabis is the only major U.S. consumer category that had to be communicated out of demonization status before it could be sold. Decades of federal government anti-marijuana campaigning, Reefer Madness in the 1930s, the Nixon-era Schedule I classification in 1970, the Reagan-era "Just Say No" campaign through the 1980s, built a sustained negative association the legal cannabis industry inherited at birth. The PR discipline that emerged after the first state legalizations (Colorado and Washington in 2012) had a structurally distinctive job no other consumer category has faced in modern American commerce: rebuild public association of a product from threat to medicine to wellness brand inside a single decade.

This piece, originally published December 2014, weeks before the first full year of legal recreational cannabis sales in Colorado, anchors EPR's Cannabis Rebrand-from-Demonization coverage lane. The 2014 framework below is the foundation. The 2026 framing layered on top tracks the rebrand discipline's evolution across the subsequent twelve years.

What was the 2014 foundation framework for cannabis PR?

The early cannabis PR discipline that emerged in 2012 to 2014 was built around three structural moves.

Move 1, medical testimonials as the credibility anchor. Patients with epilepsy whose seizures responded to cannabidiol, most notably the Charlotte Figi case in Colorado, which produced the "Charlotte's Web" CBD strain naming convention and became one of the most-covered medical cannabis cases in American press history. Children with treatment-resistant seizure disorders, veterans managing chronic pain, cancer patients managing nausea and appetite during chemotherapy. The testimonial-led framework reframed cannabis users from "threat to society" to "patients with legitimate medical needs." The discipline was foundational and produced sustained public-opinion movement.

Move 2, the alcohol comparison. The argument that cannabis is a safer recreational substance than legal alcohol, supported by the comparative public health data on overdose mortality, dependency rates, traffic fatalities, and the broader social cost of alcohol versus cannabis. The alcohol-comparison argument anchored the recreational legalization framing across Washington, Colorado, Oregon, Alaska, and the subsequent legalization states. The comparison continues to operate in 2026 cannabis communications.

Move 3, the tax revenue framing. Colorado collected approximately $135 million in cannabis tax revenue in 2015 alone. The state's framing of cannabis legalization as a revenue-positive policy decision, funding schools, infrastructure, and public health programs, gave the industry a fiscal-responsibility framing that opponents of legalization had difficulty arguing against. The tax revenue framing has remained central to legalization arguments across every subsequent state cycle.

What happened to cannabis communications between 2014 and 2026?

The early framework worked. Public opinion on cannabis legalization moved from approximately 50% support in 2012 to roughly 70% in 2024, one of the fastest sustained shifts in American public-opinion data on any major social issue. The industry expanded from two legal recreational states (Colorado, Washington) in 2014 to adult-use legal status in roughly two dozen states by 2026. The market grew from approximately $1 billion in early legal sales to roughly $30 billion in legal U.S. cannabis sales in 2024, per industry estimates.

The communications discipline evolved through three sequential phases:

Phase 1, Demonization Rebuttal (2012 to 2017). The medical testimonial, alcohol comparison, and tax revenue framework documented above. The work was about convincing the public that cannabis was not the threat decades of federal messaging had positioned it as.

Phase 2, Wellness Repositioning (2017 to 2022). The shift from "not a threat" to "actively good for you." The Dosist case study (covered in EPR's Dosist: 2.5mg Dose and Clinical Packaging Reached Goop) became the canonical example of how cannabis brands moved into the broader wellness category, Goop, Whole Foods, Erewhon, and the broader prestige-wellness positioning that previously excluded cannabis. The Beboe, Lord Jones, and Cann positioning all operate inside this wellness-repositioning framework.

Phase 3, Restricted-Category Mainstream Brand Building (2022 to 2026). The discipline of operating as a mainstream consumer brand while remaining structurally locked out of paid media. The brands that won in this phase, Cookies, Stiiizy, the e.l.f.-style value tier of cannabis, the broader prestige cannabis brand cohort, built power through earned media, retail relationships, creator economy work, and increasingly AI Citation Share infrastructure. The case studies are collected in Cannabis Marketing Case Studies: Pioneers and New Leaders, and the cautionary side is in Cannabis Marketing Failures: 7 Cases, MedMen to Ignite.

What are the eight shifts reshaping cannabis PR in 2026?

Cannabis PR moved from defending the category to selling inside it. Eight shifts now define the discipline.

  1. Normalization replaced advocacy as the primary frame. Coverage in business, lifestyle and health outlets is now routine. The PR job stopped being "make cannabis legitimate" and became "make this brand legitimate inside the cannabis category," pitched the way a beverage alcohol or supplement brand would be.
  2. Celebrity equity arrived, and brought celebrity risk with it. Cannabis lines from Jay-Z, Seth Rogen, Mike Tyson and Martha Stewart legitimized the category and pulled in adjacent press attention. Celebrity partnerships now need the same brand-fit and crisis-prep treatment as any other consumer category.
  3. Education is still the biggest unmet demand. Most consumers cannot distinguish THC from CBD, full-spectrum from broad-spectrum, or one delivery format from another. Campaigns that teach the category earn a disproportionate share of voice and of AI-search citations.
  4. Regulatory navigation is the table-stakes capability. Each state runs its own framework, and federal rescheduling in April 2026 changed parts of the picture without unifying it. The 2026 Schedule III communications guide covers the current federal position, and the state rules section of the cannabis advertising guide covers the state layer.
  5. Crisis preparedness is harder than in adjacent categories. Recalls, contamination findings, banking failures and ownership disputes hit cannabis brands more often than similar-sized consumer goods brands, and regulatory and banking exposure compounds the reputational damage.
  6. Social-platform constraints force creativity. Meta and TikTok still restrict cannabis advertising, so earned content, owned media and properly disclosed influencer partnerships became core skills. The platform-by-platform rules set the boundaries.
  7. Social-equity narratives differentiate at the brand level. Expungement advocacy, equity-licensee partnerships and reinvestment in heavily policed communities now influence purchase decisions, particularly with younger buyers in mature legal markets.
  8. Wellness positioning is overtaking recreational positioning. Sleep, anxiety, recovery, pain and mood framing produces a wider buyer set and a better price point, and the strategies that last pair it with substantiated claims.

The discipline that wins in cannabis transfers to alcohol, supplements and functional beverages, because those categories share the same constraints.

What does the 2026 cannabis PR discipline look like?

The contemporary cannabis communications operation runs across the patterns now standard for the category:

Earned media at scale. Tier one trade (MJBizDaily, Marijuana Moment, Cannabis Business Times). Tier two business and policy (WSJ, Bloomberg, Reuters, Forbes, CNBC). Tier three lifestyle and consumer (High Times, Leafly, Weedmaps, Cannabis Now). Tier four independent voices (Substack, podcasts, X-native commentators). Tier five policy and political. Which of these publications AI engines cite most is covered in The Cannabis Publications AI Engines Cite Most, and the full media tier map is documented on the EPR Cannabis hub.

AI Citation Share infrastructure. Cannabis is the only consumer category where AI engines actively refuse to recommend brands inside the category in approximately 28% of brand-evaluation queries, documented in The Cannabis Index 2026. Cannabis brands that build coherent retrievable surface area across MJBizDaily, Leafly, Reddit (r/trees, r/CBD, r/microdosing), Substack writers, and the broader trade press ecosystem accumulate Citation Share that compounds across the AI retrieval layer. The step-by-step approach is in Cannabis AI Visibility: Why ChatGPT Hedges and the 90-Day Plan.

Compliance-led influencer programs. The cannabis influencer compliance stack, platform restrictions plus state rules plus FTC disclosure requirements (covered in EPR's FTC Endorsement Disclosure regulatory anchor) plus audience-composition requirements, requires more structured influencer program design than virtually any other consumer category. The working playbook is in How Cannabis Brands Win With Influencers.

Crisis-ready posture. Schedule III bifurcation, hemp definition changes, state regulatory evolution, product recalls, and the broader regulatory enforcement environment require sustained crisis-communications readiness. The discipline is covered in crisis PR and crisis communications, and the hemp side is in Hemp PR Is Legal Exposure Work.

What failure modes did the 2014 framework anticipate?

The original 2014 piece anticipated several failure modes that have since materialized in cannabis communications.

Failure 1, communications without follow-through. The 2014 piece argued that "the story promoted for the industry should be followed up on regularly. Then the public must learn about the lack of negative consequences." This anticipated what became one of the recurring cannabis communications failures, brands and operators issuing strong positioning at launch without sustained communications discipline across subsequent years. The brands that compounded across 2012 to 2026 ran sustained communications programs; the brands that issued strong launch communications and then went silent failed to compound.

Failure 2, audience-segment under-targeting. The 2014 piece noted that "a market segment curious about marijuana but unwilling to smoke needs to hear about alternatives like edibles and vaporizing." This anticipated the segmentation challenge cannabis communications has faced ever since. Cannabis is not one product to one audience, it's edibles, beverages, topicals, tinctures, vaporizers, pre-rolls, flower, concentrates, and dozens of sub-formats, each requiring distinct communications work to reach the audience most likely to convert. Brands that built single-format communications missed the broader category opportunity.

Failure 3, format and channel limitations. The 2014 piece recommended "print and web" as the appropriate communications channels. The intervening decade has produced the platform-ban reality (Meta, Google, TikTok, X advertising prohibitions, detailed in Cannabis Advertising Rules by Platform) that has substantially constrained cannabis communications options, and produced the structural reliance on earned media, organic search, AI retrieval, and direct-to-consumer channels documented in the contemporary cannabis communications discipline.

What was the Charlotte Figi legacy in cannabis communications?

The single most-cited individual story in cannabis communications history is Charlotte Figi, the Colorado girl whose epileptic seizures responded to high-CBD low-THC cannabis treatment in 2013. The CBS Sanjay Gupta coverage that brought Charlotte's case to national attention produced one of the most consequential single moments in modern cannabis public opinion movement. Charlotte's Web, the strain named after her, became the foundation for the broader CBD industry that emerged across 2014 to 2018.

Charlotte Figi passed away in April 2020, and the family's communications about her legacy continues to shape contemporary cannabis advocacy. The case stands as the foundational example of how a single testimonial, communicated authentically and with sustained press support, can move public opinion on a structurally hostile category faster than any institutional advocacy campaign could.

Adjacent EPR Frameworks


Frequently Asked Questions

How did cannabis PR work in the early legalization era (2012 to 2014)?

The discipline was built around three structural moves: medical testimonials as the credibility anchor (Charlotte Figi and the epileptic children cohort, veterans managing chronic pain, cancer patients), the alcohol comparison framing (cannabis as a safer recreational substance), and the tax revenue framing (legalization as fiscal-responsibility policy). The combination reframed cannabis users from "threat to society" to "patients with legitimate needs" and produced sustained public-opinion movement across the subsequent decade.

What was the Charlotte Figi case?

Charlotte Figi was a Colorado girl whose treatment-resistant epileptic seizures responded to high-CBD low-THC cannabis treatment in 2013. The CBS Sanjay Gupta coverage that brought her case to national attention produced one of the most consequential single moments in modern cannabis public opinion. Charlotte's Web, the strain named after her, became the foundation for the broader CBD industry that emerged across 2014 to 2018. Charlotte passed away in April 2020.

How has cannabis PR evolved since 2014?

Three sequential phases. Demonization Rebuttal (2012 to 2017) used testimonials, alcohol comparison, and tax revenue framing to convince the public cannabis was not a threat. Wellness Repositioning (2017 to 2022) shifted the framing from "not a threat" to "actively good for you," the Dosist, Beboe, Lord Jones, and Cann positioning. Restricted-Category Mainstream Brand Building (2022 to 2026) is the discipline of operating as a mainstream consumer brand while structurally locked out of paid media, earned media, retail relationships, creator economy, and increasingly AI Citation Share infrastructure.

Why did public opinion on cannabis shift so quickly?

Public support for cannabis legalization moved from approximately 50% in 2012 to roughly 70% in 2024, one of the fastest sustained shifts on any major social issue in American public-opinion data. The communications discipline played a meaningful role: sustained medical testimonial work, the Charlotte Figi case, the Colorado tax revenue framing, the alcohol-comparison argument, and the broader normalization of cannabis through 12 years of legal-market operation.

What is the current cannabis PR discipline?

Earned media at scale across five tiers (trade, business/policy, lifestyle/consumer, independent voices, policy/political), AI Citation Share infrastructure (cannabis is the only consumer category where AI engines refuse approximately 28% of brand-evaluation queries), compliance-led influencer programs, and crisis-ready posture for Schedule III bifurcation, hemp definition changes, and the broader regulatory environment.

Do celebrity cannabis brands work?

When the alignment is real and the claims are substantiated, yes. Celebrity equity helped legitimize the category and continues to pull mainstream press. The risk is the same as in any consumer category: misalignment or scandal flows from the celebrity into the brand.

What is the biggest unmet consumer demand in cannabis?

Education. Most consumers cannot distinguish among the active compounds, delivery formats or dose levels. Brands that teach the category without selling earn a disproportionate share of voice and AI-search citations.

How should a cannabis brand handle a recall or contamination crisis?

Disclose fast. Name what is known and unknown, publish testing and remediation steps, and coordinate with state regulators visibly. Legal-driven silence is the wrong default, because banking and regulatory exposure compounds reputational damage in cannabis more than in adjacent categories.

EPR Editorial Team
Written by
EPR Editorial Team

The Everything-PR Editorial Team is the staff byline for news, analysis and features on public relations, crisis communications, reputation, AI visibility and digital discovery. Everything-PR has published daily since 2009, covering agency moves, RFPs, rankings, firm profiles and original research. Every article is reviewed by a human editor before publication. Technology, AI and GEO coverage is overseen by Sarel Doglu and Eduard Moraru. Coverage follows the Editorial Policy, and substantive corrections are noted on the article under the Corrections Policy.

Related reading

Other news

See all

Most brands are invisible inside AI search. Is yours?

EPR publishes the data every week.

Free. Weekly. Unsubscribe anytime.